Received therapy of curative intent (surgery or radiotherapy)
Have a rising PSA which has doubled from a nadir value.
Histologically proven prostate cancer requiring androgen deprivation therapy for at least 12 months
Written informed consent to participate in the trial.
You may not be if
Known hypersensitivity to Zoladex, Casodex, ar any component of these products
Prior treatment with LHRH agonist or anti-androgens in the past 12 months
Any concomitant condition that would make it undesirable, in the physician's opinion, for the subject to participate in the trial or would jeopardize compliance with the protocol.
Clareo Health | Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 Year
